Abstract:Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) mediated by CD4+ T helper (Th) cells, and characterized by immune cell infiltration, demyelination and neurodegeneration, with no definitive cure available. Thus, it is pivotal and imperative to acquire more profound comprehension of the underlying mechanisms implicated in MS. Dysregulated immune responses are widely believed to play a primary role in the pathogenesis of MS. Recently, a plethora of studies have demonstrated the involvement of T follicular helper (Tfh) cells and tertiary lymphoid-like structures (TLSs) in the pathogenesis and progression of MS. Cathepsin C (CatC) is a cysteine exopeptidase which is crucial for the activation of immune-cell-associated serine proteinases in many inflammatory diseases in peripheral system, such as rheumatoid arthritis and septicemia. We have previously demonstrated that CatC is involved in neuroinflammation and exacerbates demyelination in both cuprizone-induced and experimental autoimmune encephalomyelitis (EAE) mouse models. However, the underlying immunopathological mechanism remains elusive. In the present study, we established a recombinant myelin oligodendrocyte glycoprotein 35-55 peptide-induced EAE model using conditional CatC overexpression mice to investigate the effects of CatC on the alteration of CD4+ Th subsets, including Th1, Th2, Th17, Tfh and T regulatory cells. Our findings demonstrated that CatC particularly enhanced the population of Tfh cell in the brain, resulting in the earlier onset and more severe chronic syndrome of EAE. Furthermore, CatC promoted the formation of TLSs in the brain, leading to persistent neuroinflammation and exacerbating the severity of EAE in the chronic phase. Conversely, treatment with AZD7986, a specific inhibitor of CatC, effectively attenuated the syndrome of EAE and its effects caused by CatC both in vivo and in vitro. These findings provide a novel insight into the critical role of CatC in innate and adaptive immunity in EAE, and specific inhibitor of CatC, AZD7986, may contribute to potential therapeutic strategies for MS.

The C-type lectin receptor Clec1A plays an important role in the development of experimental autoimmune encephalomyelitis by enhancing antigen presenting ability of dendritic cells and inducing inflammatory cytokine IL-17

The deficient CLEC5A ameliorates the behavioral and pathological deficits via the microglial Aβ clearance in Alzheimer's disease mouse model

Cd1-Dependent Regulation of Chronic Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis

CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury

C16 Peptide Shown to Prevent Leukocyte Infiltration and Alleviate Detrimental Inflammation in Acute Allergic Encephalomyelitis Model

Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection

Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway

CD226 Attenuates Treg Suppressive Capacity Via CTLA-4 and TIGIT During EAE

Clec12a Inhibits MSU-induced Immune Activation Through Lipid Raft Expulsion.

Identification of Clec4b As a Novel Regulator of Bystander Activation of Auto-Reactive T Cells and Autoimmune Disease

Clec12a tempers inflammation while restricting expansion of a colitogenic commensal

The C-Type Lectin Clec12a Present on Mouse and Human Dendritic Cells Can Serve As A Target for Antigen Delivery and Enhancement of Antibody Responses

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

Il-9 is Important for T-Cell Activation and Differentiation in Autoimmune Inflammation of the Central Nervous System

CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model

T-cell-specific Sel1L Deletion Exacerbates EAE by Promoting Th1/Th17-cell Differentiation.

Cathepsin C exacerbates EAE by promoting the expansion of Tfh cells and the formation of TLSs in the CNS

Role of IL-12 Receptor β1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis

CD226 Ligation Protects Against EAE by Promoting IL-10 Expression Via Regulation of CD4+ T Cell Differentiation.

Kit (W-Sh) Mice Develop Earlier And More Severe Experimental Autoimmune Encephalomyelitis Due To Absence Of Immune Suppression

CCDC134 Ameliorated Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells